I. D. Kuznetsov

I. D. Kuznetsov

Auto-generated profile, based on publicly available information

I. D. Kuznetsov

Academician E. A. Wagner Perm State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Russian Journal of Clinical Dermatology and Venereology
Verified
Journal Article
Closed access
VEV.D. Elkin
V.D. Elkin
EPE.V. Plotnikova
E.V. Plotnikova
MKM.Yu. Kobernik
M.Yu. Kobernik
IKI.D. Kuznetsov
I.D. Kuznetsov
TST.G. Sedova
T.G. Sedova
В статье представлены краткая характеристика ботулинического токсина, история его применения в медицинской практике, приведены основные показания к использованию в настоящее время. Особое внимание уделено коррекции косметических недостатков лица: гиперфункциональных мимических морщин, изменения овала лица. Описана технология производства ботулинического токсина. Подробно изложен механизм его действия, заключающийся в блокаде нейромышечных связей с развитием функциональной денервации мышц, также отражен процесс реиннервации, который развивается благодаря процессу спраутинга. Рассмотрены сравнительная характеристика и фармакологические особенности основных препаратов ботулотоксина типа A; приведены сведения о ботулотоксинах других серотипов. Описаны клиническая эффективность и переносимость препаратов ботулотоксинов, их биологическая активность, длительность действия, абсолютные и относительные противопоказания к применению, а также побочные реакции, включая ботулинофилию и формирование «маски ботокса». Отмечено, что разные препараты ботулотоксинов не взаимозаменяемы, а рекомендации по подбору доз не могут основываться на каком-то единственном перерасчетном коэффициенте. Уделено внимание образованию антител к ботулотоксинам, оказывающим влияние на выраженность и время действия препаратов. Показано, что результат ботулинотерапии в большой степени зависит от правильного выполнения техники инъекций: определения оптимальной дозы ботулотоксина и выбора мышц-мишеней. Данные литературы свидетельствуют об эффективности и безопасности применения ботулотоксина для коррекции инволюционных изменений лица.

26 December 2022 in Лечащий врач
Verified
Journal Article
Closed access
IKI.A. Kuklin
I.A. Kuklin
MKM.M. Kokhan
M.M. Kokhan
VIV.A. Iglikov
V.A. Iglikov
IKI.D. Kuznetsov
I.D. Kuznetsov
MKM.K. Kuklina
M.K. Kuklina
ERE.V. Redkina
E.V. Redkina
The article presents basic information about cutaneous leiomyoma – a rare benign tumor of the skin from smooth muscles. The most common leiomyomas of the skin from the muscles that raise the hair, which are inherited in an autosomal dominant manner, manifest mainly in adulthood and occur in men 2 times more often than in women. The clinical picture is characterized by nodules of a hemispherical shape, densely elastic consistency, flesh-colored, pink and red in color with a brownish or bluish tinge, ranging in size from 0.1 mm to 2 cm in diameter, with a smooth and shiny surface, which are located asymmetrically, isolated or grouped on the scalp, lateral surfaces of the neck, trunk and lower extremities. It is known that the most common complaint in patients is pain of varying severity in the area of the nodules. Pain of varying severity in the area of nodules is the most common complaint in patients and can occur spontaneously or be provoked by any mechanical irritation of the skin, cold, as well as emotional stress. This pain syndrome in patients has been well studied and described in clinical practice, at the same time, there are no indications in the specialized dermatovenerological literature of the occurrence of pain in patients during sleep. The case of the diagnostics of cutaneous leiomyoma of the muscles lifting hair is presented in a 66-year-old patient who consulted a dermatovenerologist at the clinic of the Ural Research Institute of Dermatovenereology and Immunopathology. The diagnosis was verified by a pathomorphological study of a skin biopsy. A detailed study of the patient's anamnesis and complaints revealed episodes of unbearable pain in the projection of rashes that occur during emotionally colored dreams. A new clinical syndrome of the disease is described – myalgia in the rem sleep, which can be explained by the predominance of the sympathetic nervous system and the activation of physiological functions of the body during dreams.

7 March 2024 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
IKI. A. Kuklin
I. A. Kuklin
MKM. M. Kokhan
M. M. Kokhan
ASA. N. Shakirova
A. N. Shakirova
YKY. V. Kashcheeva
Y. V. Kashcheeva
ORO. G. Rimar
O. G. Rimar
ЯКЯ. В. Кащеева
Я. В. Кащеева
Introduction. Mycosis Fungoides (MF) is a primary epidermotropic T-cell lymphoma characterized by clonal proliferation of small and medium-sized T-lymphocytes with cerebriform nuclei. MF accounts for ≥ 50 % of all cutaneous lymphomas.The purpose of the study — description of a rare clinical observation of the debut of the development of Mycosis Fungoides in a patient in adolescence.Materials and methods. To verify the diagnosis, pathomorphological and immunohistochemical examination of a skin biopsy from the most infiltrated tumor-like lesion was used. The patient, born in 1978, turned to the clinic of Ural Research Institute of Dermatovenerology and Immunopathology with complaints of rashes on the skin of the trunk, accompanied by itching and soreness. Patient had been ill since the age of 16, when he first noticed the appearance of red spots on the skin of the chest without subjective sensations. In the last year he noted a significant deterioration of the disease: an increase in the number of spots, an increase in the intensity of itching, the appearance of tumor-like elements on the skin of the buttocks. In December 2022, he visited a dermatovenerologist and, in order to clarify the diagnosis, was sent to the Ural Research Institute of Dermatovenerology and Immunopathology.Discussion. The etiopathogenesis of the disease and the analysis of the few literature sources on the topic allows us to see the difficulty in early diagnosis and diagnosis in patients with early clinical manifestations of GM.Results. This clinical case demonstrates the possibility of the debut of GM in adolescence, the complexity of diagnosis in the early stages of development.Conclusion. The clinical case demonstrates the debut of GM in adolescence, emphasizes the need for clinical oncological alertness among dermatovenerologists.

30 December 2021 in Лечащий врач
Verified
Journal Article
Closed access
IKI.A. Kuklin
I.A. Kuklin
NMN.P. Malishevskaya
N.P. Malishevskaya
MKM.M. Kokhan
M.M. Kokhan
GSG.D. Safonova
G.D. Safonova
ORO.G. Rimar
O.G. Rimar
MKM.K. Kuklina
M.K. Kuklina
The article presents a brief review of the literature about clinical manifestations, modern methods of diagnosticsand treatment of an extremely rare disease – generalized eruptive keratoacanthomas of Grzybowski. The disease is characterized by the appearance of hundreds or thousands of generalized itchy nodules on the skin of the face, trunk, limbs, genitals, oral mucosa and larynx within a short time. The disease develops at the age of over 40, has a recurrent course, spontaneous involution of individual elements with the formation of areas of depigmentation or atrophic scars is possible. The authors describe a case of their own clinical care of generalized eruptive keratoacanthomas of Grzybowski in a 50-year-old patient who consulted a dermatovenerologist at the clinic of the Ural Research Institute of Dermatovenerology and Immunopathology.The duration of the disease at the time of visit to a doctor was 2,5 years, its occurrence was preceded by repeated visits to countries with excessive insolation, which can be considered as an etiological factor in the development of the disease. The diagnosis was first suspected at a boarddermatovenerologists based on the clinical picture of the disease and subsequently verified by the data of a pathomorphological examination of the biopsy of the affected skin.The effectiveness of the use of aromatic retinoids in the treatment of generalized eruptive keratoacanthomas of Grzybowski is shown and the side effects that developed in the patient with an independent increase in the dose of acitretin to 70 mg/day are given. The article states the extremely rare occurrence of this disease, as evidenced by the above clinical case, diagnosed for the first time in more than 90 years of the institute's existence. The importance of consolidating the clinical experience of several leading dermatovenerologists for the diagnostics of generalized eruptive keratoacanthomas of Grzybowski is emphasized.